Click for best price
Cytomegalovirus HHV5 Infection Therapeutic Drugs Market Size, Share 2023
A drug used to treat giant cell infections.
This report aims to provide a comprehensive presentation of the global market for Cytomegalovirus (HHV-5) Infection Therapeutic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cytomegalovirus (HHV-5) Infection Therapeutic Drugs. This report contains market size and forecasts of Cytomegalovirus (HHV-5) Infection Therapeutic Drugs in global, including the following market information:
Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oral Medication Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cytomegalovirus (HHV-5) Infection Therapeutic Drugs include 3-V Biosciences, Inc., AIMM Therapeutics, AlphaVax, Altor BioScience, Applied Immune, Astellas, BioApex, Bionor Pharma and Biotest, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cytomegalovirus (HHV-5) Infection Therapeutic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Segment Percentages, by Type, 2022 (%)
Oral Medication
Injection
Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cytomegalovirus (HHV-5) Infection Therapeutic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cytomegalovirus (HHV-5) Infection Therapeutic Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3-V Biosciences, Inc.
AIMM Therapeutics
AlphaVax
Altor BioScience
Applied Immune
Astellas
BioApex
Bionor Pharma
Biotest
Pfizer
Cell Medica
Chimerix
GSK
Hookipa Biotech
Humabs BioMed
Inagen
Kadmon Corporation
Lead Discovery Center
Merck
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cytomegalovirus (HHV-5) Infection Therapeutic Drugs, market overview.
Chapter 2: Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs market size in revenue.
Chapter 3: Detailed analysis of Cytomegalovirus (HHV-5) Infection Therapeutic Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cytomegalovirus (HHV-5) Infection Therapeutic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
113 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Overall Market Size
2.1 Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size: 2022 VS 2030
2.2 Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Players in Global Market
3.2 Top Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Companies Ranked by Revenue
3.3 Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size Markets, 2022 & 2030
4.1.2 Oral Medication
4.1.3 Injection
4.2 By Type - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue & Forecasts
4.2.1 By Type - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, 2024-2030
4.2.3 By Type - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue & Forecasts
5.2.1 By Application - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, 2024-2030
5.2.3 By Application - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2022 & 2030
6.2 By Region - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue & Forecasts
6.2.1 By Region - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, 2024-2030
6.2.3 By Region - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, 2018-2030
6.3.2 US Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.3.3 Canada Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.3.4 Mexico Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, 2018-2030
6.4.2 Germany Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.4.3 France Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.4.4 U.K. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.4.5 Italy Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.4.6 Russia Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.4.8 Benelux Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, 2018-2030
6.5.2 China Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.5.3 Japan Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.5.4 South Korea Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.5.6 India Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, 2018-2030
6.6.2 Brazil Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.6.3 Argentina Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, 2018-2030
6.7.2 Turkey Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.7.3 Israel Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
6.7.5 UAE Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, 2018-2030
7 Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Companies Profiles
7.1 3-V Biosciences, Inc.
7.1.1 3-V Biosciences, Inc. Company Summary
7.1.2 3-V Biosciences, Inc. Business Overview
7.1.3 3-V Biosciences, Inc. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.1.4 3-V Biosciences, Inc. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.1.5 3-V Biosciences, Inc. Key News & Latest Developments
7.2 AIMM Therapeutics
7.2.1 AIMM Therapeutics Company Summary
7.2.2 AIMM Therapeutics Business Overview
7.2.3 AIMM Therapeutics Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.2.4 AIMM Therapeutics Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.2.5 AIMM Therapeutics Key News & Latest Developments
7.3 AlphaVax
7.3.1 AlphaVax Company Summary
7.3.2 AlphaVax Business Overview
7.3.3 AlphaVax Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.3.4 AlphaVax Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.3.5 AlphaVax Key News & Latest Developments
7.4 Altor BioScience
7.4.1 Altor BioScience Company Summary
7.4.2 Altor BioScience Business Overview
7.4.3 Altor BioScience Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.4.4 Altor BioScience Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.4.5 Altor BioScience Key News & Latest Developments
7.5 Applied Immune
7.5.1 Applied Immune Company Summary
7.5.2 Applied Immune Business Overview
7.5.3 Applied Immune Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.5.4 Applied Immune Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.5.5 Applied Immune Key News & Latest Developments
7.6 Astellas
7.6.1 Astellas Company Summary
7.6.2 Astellas Business Overview
7.6.3 Astellas Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.6.4 Astellas Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.6.5 Astellas Key News & Latest Developments
7.7 BioApex
7.7.1 BioApex Company Summary
7.7.2 BioApex Business Overview
7.7.3 BioApex Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.7.4 BioApex Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.7.5 BioApex Key News & Latest Developments
7.8 Bionor Pharma
7.8.1 Bionor Pharma Company Summary
7.8.2 Bionor Pharma Business Overview
7.8.3 Bionor Pharma Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.8.4 Bionor Pharma Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.8.5 Bionor Pharma Key News & Latest Developments
7.9 Biotest
7.9.1 Biotest Company Summary
7.9.2 Biotest Business Overview
7.9.3 Biotest Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.9.4 Biotest Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.9.5 Biotest Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.10.4 Pfizer Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 Cell Medica
7.11.1 Cell Medica Company Summary
7.11.2 Cell Medica Business Overview
7.11.3 Cell Medica Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.11.4 Cell Medica Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.11.5 Cell Medica Key News & Latest Developments
7.12 Chimerix
7.12.1 Chimerix Company Summary
7.12.2 Chimerix Business Overview
7.12.3 Chimerix Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.12.4 Chimerix Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.12.5 Chimerix Key News & Latest Developments
7.13 GSK
7.13.1 GSK Company Summary
7.13.2 GSK Business Overview
7.13.3 GSK Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.13.4 GSK Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.13.5 GSK Key News & Latest Developments
7.14 Hookipa Biotech
7.14.1 Hookipa Biotech Company Summary
7.14.2 Hookipa Biotech Business Overview
7.14.3 Hookipa Biotech Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.14.4 Hookipa Biotech Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.14.5 Hookipa Biotech Key News & Latest Developments
7.15 Humabs BioMed
7.15.1 Humabs BioMed Company Summary
7.15.2 Humabs BioMed Business Overview
7.15.3 Humabs BioMed Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.15.4 Humabs BioMed Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.15.5 Humabs BioMed Key News & Latest Developments
7.16 Inagen
7.16.1 Inagen Company Summary
7.16.2 Inagen Business Overview
7.16.3 Inagen Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.16.4 Inagen Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.16.5 Inagen Key News & Latest Developments
7.17 Kadmon Corporation
7.17.1 Kadmon Corporation Company Summary
7.17.2 Kadmon Corporation Business Overview
7.17.3 Kadmon Corporation Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.17.4 Kadmon Corporation Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.17.5 Kadmon Corporation Key News & Latest Developments
7.18 Lead Discovery Center
7.18.1 Lead Discovery Center Company Summary
7.18.2 Lead Discovery Center Business Overview
7.18.3 Lead Discovery Center Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.18.4 Lead Discovery Center Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.18.5 Lead Discovery Center Key News & Latest Developments
7.19 Merck
7.19.1 Merck Company Summary
7.19.2 Merck Business Overview
7.19.3 Merck Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.19.4 Merck Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.19.5 Merck Key News & Latest Developments
7.20 Novartis
7.20.1 Novartis Company Summary
7.20.2 Novartis Business Overview
7.20.3 Novartis Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Major Product Offerings
7.20.4 Novartis Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global Market (2018-2023)
7.20.5 Novartis Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Opportunities & Trends in Global Market
Table 2. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Drivers in Global Market
Table 3. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Restraints in Global Market
Table 4. Key Players of Cytomegalovirus (HHV-5) Infection Therapeutic Drugs in Global Market
Table 5. Top Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Type
Table 9. List of Global Tier 1 Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 30. 3-V Biosciences, Inc. Company Summary
Table 31. 3-V Biosciences, Inc. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 32. 3-V Biosciences, Inc. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. 3-V Biosciences, Inc. Key News & Latest Developments
Table 34. AIMM Therapeutics Company Summary
Table 35. AIMM Therapeutics Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 36. AIMM Therapeutics Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. AIMM Therapeutics Key News & Latest Developments
Table 38. AlphaVax Company Summary
Table 39. AlphaVax Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 40. AlphaVax Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. AlphaVax Key News & Latest Developments
Table 42. Altor BioScience Company Summary
Table 43. Altor BioScience Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 44. Altor BioScience Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Altor BioScience Key News & Latest Developments
Table 46. Applied Immune Company Summary
Table 47. Applied Immune Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 48. Applied Immune Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Applied Immune Key News & Latest Developments
Table 50. Astellas Company Summary
Table 51. Astellas Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 52. Astellas Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Astellas Key News & Latest Developments
Table 54. BioApex Company Summary
Table 55. BioApex Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 56. BioApex Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. BioApex Key News & Latest Developments
Table 58. Bionor Pharma Company Summary
Table 59. Bionor Pharma Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 60. Bionor Pharma Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Bionor Pharma Key News & Latest Developments
Table 62. Biotest Company Summary
Table 63. Biotest Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 64. Biotest Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Biotest Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 68. Pfizer Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. Cell Medica Company Summary
Table 71. Cell Medica Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 72. Cell Medica Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Cell Medica Key News & Latest Developments
Table 74. Chimerix Company Summary
Table 75. Chimerix Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 76. Chimerix Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Chimerix Key News & Latest Developments
Table 78. GSK Company Summary
Table 79. GSK Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 80. GSK Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. GSK Key News & Latest Developments
Table 82. Hookipa Biotech Company Summary
Table 83. Hookipa Biotech Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 84. Hookipa Biotech Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Hookipa Biotech Key News & Latest Developments
Table 86. Humabs BioMed Company Summary
Table 87. Humabs BioMed Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 88. Humabs BioMed Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Humabs BioMed Key News & Latest Developments
Table 90. Inagen Company Summary
Table 91. Inagen Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 92. Inagen Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 93. Inagen Key News & Latest Developments
Table 94. Kadmon Corporation Company Summary
Table 95. Kadmon Corporation Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 96. Kadmon Corporation Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 97. Kadmon Corporation Key News & Latest Developments
Table 98. Lead Discovery Center Company Summary
Table 99. Lead Discovery Center Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 100. Lead Discovery Center Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 101. Lead Discovery Center Key News & Latest Developments
Table 102. Merck Company Summary
Table 103. Merck Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 104. Merck Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 105. Merck Key News & Latest Developments
Table 106. Novartis Company Summary
Table 107. Novartis Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Offerings
Table 108. Novartis Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 109. Novartis Key News & Latest Developments
List of Figures
Figure 1. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Segment by Type in 2022
Figure 2. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Segment by Application in 2022
Figure 3. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in 2022
Figure 8. By Type - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 16. US Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 28. China Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. 3-V Biosciences, Inc. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AIMM Therapeutics Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AlphaVax Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Altor BioScience Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Applied Immune Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Astellas Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. BioApex Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bionor Pharma Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Biotest Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Pfizer Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Cell Medica Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Chimerix Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. GSK Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Hookipa Biotech Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Humabs BioMed Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Inagen Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Kadmon Corporation Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Lead Discovery Center Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Merck Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Novartis Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
